Literature DB >> 16941381

Adherence to antiretroviral therapy: how much is enough?

Roy M Gulick.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16941381     DOI： 10.1086/507549

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  12 in total

1.  Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART).

Authors:  Shilpa Viswanathan; Roger Detels; Shruti H Mehta; Bernard J C Macatangay; Gregory D Kirk; Lisa P Jacobson
Journal:  AIDS Behav       Date:  2015-04

2.  Influence of CYP2B6 516G>T polymorphism and interoccasion variability (IOV) on the population pharmacokinetics of efavirenz in HIV-infected South African children.

Authors:  M Viljoen; M O Karlsson; T M Meyers; H Gous; C Dandara; M Rheeders
Journal:  Eur J Clin Pharmacol       Date:  2011-11-06       Impact factor: 2.953

3.  Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users.

Authors:  M J Milloy; Thomas Kerr; Jane Buxton; Tim Rhodes; Silvia Guillemi; Robert Hogg; Julio Montaner; Evan Wood
Journal:  J Infect Dis       Date:  2011-05-01       Impact factor: 5.226

4.  Medical mistrust is related to lower longitudinal medication adherence among African-American males with HIV.

Authors:  Sannisha K Dale; Laura M Bogart; Glenn J Wagner; Frank H Galvan; David J Klein
Journal:  J Health Psychol       Date:  2014-10-07

5.  Validation of a New Three-Item Self-Report Measure for Medication Adherence.

Authors:  Ira B Wilson; Yoojin Lee; Joanne Michaud; Floyd J Fowler; William H Rogers
Journal:  AIDS Behav       Date:  2016-11

6.  Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique.

Authors:  Cynthia R Pearson; Mark A Micek; Jane M Simoni; Peter D Hoff; Eduardo Matediana; Diane P Martin; Stephen S Gloyd
Journal:  J Acquir Immune Defic Syndr       Date:  2007-10-01       Impact factor: 3.731

7.  Effect of early versus deferred antiretroviral therapy for HIV on survival.

Authors:  Mari M Kitahata; Stephen J Gange; Alison G Abraham; Barry Merriman; Michael S Saag; Amy C Justice; Robert S Hogg; Steven G Deeks; Joseph J Eron; John T Brooks; Sean B Rourke; M John Gill; Ronald J Bosch; Jeffrey N Martin; Marina B Klein; Lisa P Jacobson; Benigno Rodriguez; Timothy R Sterling; Gregory D Kirk; Sonia Napravnik; Anita R Rachlis; Liviana M Calzavara; Michael A Horberg; Michael J Silverberg; Kelly A Gebo; James J Goedert; Constance A Benson; Ann C Collier; Stephen E Van Rompaey; Heidi M Crane; Rosemary G McKaig; Bryan Lau; Aimee M Freeman; Richard D Moore
Journal:  N Engl J Med       Date:  2009-04-01       Impact factor: 91.245

8.  Highly specific reasons for nonadherence to antiretroviral therapy: results from the German adherence study.

Authors:  Johanna Boretzki; Eva Wolf; Carmen Wiese; Sebastian Noe; Annamaria Balogh; Anja Meurer; Ivanka Krznaric; Alexander Zink; Christian Lersch; Christoph D Spinner
Journal:  Patient Prefer Adherence       Date:  2017-11-08       Impact factor: 2.711

9.  Why it Worked: Participants' Insights into an mHealth Antiretroviral Therapy Adherence Intervention in China.

Authors:  Lora L Sabin; Lauren Mansfield; Mary Bachman DeSilva; Taryn Vian; Zhong Li; Xie Wubin; Allen L Gifford; Yiyao Barnoon; Christopher J Gill
Journal:  Open AIDS J       Date:  2018-03-12

10.  Virologic outcome among patients receiving antiretroviral therapy at five hospitals in Haiti.

Authors:  Frantz Jean Louis; Josiane Buteau; Kesner François; Erin Hulland; Jean Wysler Domerçant; Chunfu Yang; Jacques Boncy; Robert Burris; Valerie Pelletier; Nicholas Wagar; Varough Deyde; David W Lowrance; Macarthur Charles
Journal:  PLoS One       Date:  2018-01-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.